CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 42,763	$ 5,927
Interest, accounts receivable, and other receivables	3,860	5,788
Assets held for sale, net (Note 6)	0	6,398
Other current assets	163	2,141
Total current assets	46,786	20,254
Finance receivables, net of allowance for credit losses of $7,278 and $11,249 as of December 31, 2025 and 2024, respectively	218,627	277,760
Collateral on foreign currency forward contract	0	2,750
Marketable investments	184	580
Deferred tax assets, net	912	23,484
Warrant assets	5,913	4,366
Other non-current assets, net	0	3,041
Total assets	272,422	332,235
Current liabilities:
Accounts payable and accrued liabilities	4,974	2,810
Liabilities held for sale, net (Note 6)	0	1,255
Deferred income	0	1,500
Total current liabilities	4,974	5,565
Unsecured senior notes, net	32,110	31,412
Revolving credit facility	0	6,233
Other non-current liabilities	240	335
Total liabilities	37,324	43,545
Commitments and contingencies (Note 8)
Stockholders' equity:
Preferred stock, $0.001 par value; 5,000,000 shares authorized; no shares issued and outstanding	0	0
Common stock, $0.001 par value; 250,000,000 shares authorized; 12,095,979 and 12,213,599 shares issued and outstanding as of December 31, 2025 and 2024, respectively	12	12
Additional paid-in capital	4,418,010	4,419,991
Accumulated deficit	(4,182,924)	(4,131,313)
Total stockholders' equity	235,098	288,690
Total liabilities and stockholders' equity	$ 272,422	$ 332,235